Once-Daily Trospium Chloride 60 mg Extended Release in Subjects with Overactive Bladder Syndrome Who Use Multiple Concomitant Medications: Post hoc Analysis of Pooled Data from Two Randomized, Placebo-Controlled Trials.
Background: Overactive bladder syndrome (OAB) is associated with various co-morbidities; treatment of these frequently results in multiple medication use (MMU) and the potential for drug-drug interactions, which may lead to adverse events and altered efficacy. With the aging population, the prevalen...
| Published in: | Drugs & Aging Vol. 28; no. 2; pp. 151 - 161 |
|---|---|
| Main Authors: | , , , |
| Format: | clinical trial equations & formulas research tables/charts Journal Article |
| Published: |
Springer Nature
2011
|
| Online Access: | View this record in EBSCOhost |